Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 14, Number 3—March 2008

Research

Hantavirus RNA in Saliva from Patients with Hemorrhagic Fever with Renal Syndrome

Lisa Pettersson*, Jonas Klingström*†‡, Jonas Hardestam†‡, Åke Lundkvist†‡, Clas Ahlm*, and Magnus Evander*Comments to Author 
Author affiliations: *Umeå University, Umeå, Sweden; †Swedish Institute for Infectious Disease Control, Solna, Sweden; ‡Karolinska Institutet, Stockholm, Sweden;

Main Article

Table

Comparison between detection of PUUV RNA in saliva and plasma and antibodies in serum samples from 14 patients with nephropathia epidemica*

Patient no. Sex Age, y Date saliva collected (d of disease) PUUV RNA† in saliva, copies/mL PUUV RNA† in plasma,‡ copies/mL PUUV IgM§ in serum‡ PUUV IgG titer in serum‡
1 M 65 6 121,323 959,294 + 40
2 M 64 2 66,994 117,562 + 80
3 M 33 5 44,898 40,427 + >640
4 F 38 6 17,516 1,381,413 + 40
5 F 59 9 9,582 3,724 + >640
6 M 54 5 6,372 26,626 320
7 M 39 7 3,745 189,233 + 320
8 M 28 5 2,589 36,231 + >640
9 F 26 5 2,163 54,315 + 80
10 F 39 5 1,530 3,044 + 80
11 M 38 6 0 1,952 ± >640
12 M 41 6 0 5,215 + 40
13 F 57 2 0 41,271 + 320
14 F 62 7 0 81,330 + 160

*PUUV, Puumala virus; Ig, immunoglobulin.
†Detected by real-time reverse transcription–PCR.
‡Most plasma and serum samples were collected the same day or within 1 day before or after the saliva sample and antibody was detected by immunofluorescence assay.
§Serum was diluted 1:16 and scored as negative (–), positive (+), or weakly positive (±).

Main Article

TOP